GR
GRI Bio, Inc.
GRI · NASDAQ
$1.81 -0.55% (-$0.01)
1M +6.43%
Market Cap $162.6K
P/E Ratio -
Div. Yield -
ROE 134.03%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.02x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 134.03%
ROA 84.88%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 10.30x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 169.48%
Profitable years 0
Beta -0.66x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na GRI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
W. Marc Hertz
Employees
4
Headquarters
La Jolla
Nadcházející události
13 LIS
Earnings
Upcoming earnings report